Skip to content

Efficacy of Platelet Rich Plasma in Plantar Fasciitis

Plantar Fasciitis Treatment: Double Blinded Randomized Control Study of the Efficacy of an Injection of Platelet Rich Plasma (PRP) Versus an Infiltration of Corticosteroids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03857334
Acronym
APOPLANT
Enrollment
50
Registered
2019-02-27
Start date
2016-07-01
Completion date
2018-12-31
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fascitis

Brief summary

Plantar fasciitis is a common pathology among podiatry moreover the healing time takes several months. The main aim of this study is to evaluate the efficacy of a injection of Platelet-Rich Plasma (PRP) versus corticosteroid injection.

Interventions

BIOLOGICALInjection of autologous platelet rich plasma
DRUGInjection of cortivazol : Altim®

Corticosteroids

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Plantar fasciitis * Average VAS greater than or equal to 5/10 * Resistance of medical reference treatment

Exclusion criteria

* Other plantar lesion find on RMI * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Mean daily pain measured with a visual analog scale from 0 to 106 monthsComparison of pain intensity, measured with a visual analog scale from 0 to 10

Secondary

MeasureTime frameDescription
Pain intensity during the first steps of the day measured with a visual analog scale from 0 to 106 monthsMeasured with a visual analog scale from 0 to 10
Pain intensity on direct compression measured with a visual analog scale from 0 to 106 monthsConstant intensity of the compression, measured with a visual analog scale from 0 to 10
Impairment of walking function6 monthsFoot function index

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026